9th Circ. Doubts Timeliness Of Amgen Off-Label Sales Suit
A Ninth Circuit panel on Friday seemed skeptical that a proposed class action alleging Amgen pushed off-label uses of an anemia drug was filed within the statute of limitations, repeatedly asking...To view the full article, register now.
Already a subscriber? Click here to view full article